Eli Lilly and Co (LLY)
787.75
+9.57
(+1.23%)
USD |
NYSE |
Mar 28, 10:10
Eli Lilly Price to Book Value: 69.53 for March 28, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
March 27, 2024 | 68.68 |
March 26, 2024 | 68.40 |
March 25, 2024 | 68.24 |
March 22, 2024 | 68.02 |
March 21, 2024 | 67.99 |
March 20, 2024 | 68.22 |
March 19, 2024 | 68.21 |
March 18, 2024 | 67.32 |
March 15, 2024 | 66.57 |
March 14, 2024 | 67.14 |
March 13, 2024 | 66.89 |
March 12, 2024 | 66.63 |
March 11, 2024 | 64.82 |
March 08, 2024 | 67.27 |
March 07, 2024 | 68.86 |
March 06, 2024 | 68.83 |
March 05, 2024 | 68.63 |
March 04, 2024 | 69.93 |
March 01, 2024 | 69.03 |
February 29, 2024 | 66.52 |
February 28, 2024 | 66.87 |
February 27, 2024 | 67.48 |
February 26, 2024 | 68.09 |
February 23, 2024 | 67.88 |
February 22, 2024 | 67.89 |
Date | Value |
---|---|
February 21, 2024 | 65.80 |
February 20, 2024 | 66.66 |
February 16, 2024 | 68.98 |
February 15, 2024 | 66.79 |
February 14, 2024 | 66.75 |
February 13, 2024 | 65.48 |
February 12, 2024 | 64.98 |
February 09, 2024 | 65.23 |
February 08, 2024 | 64.84 |
February 07, 2024 | 63.93 |
February 06, 2024 | 62.14 |
February 05, 2024 | 62.24 |
February 02, 2024 | 58.84 |
February 01, 2024 | 58.21 |
January 31, 2024 | 56.90 |
January 30, 2024 | 56.85 |
January 29, 2024 | 56.85 |
January 26, 2024 | 56.34 |
January 25, 2024 | 55.32 |
January 24, 2024 | 55.85 |
January 23, 2024 | 55.50 |
January 22, 2024 | 55.60 |
January 19, 2024 | 55.40 |
January 18, 2024 | 54.94 |
January 17, 2024 | 55.43 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
12.74
Minimum
Mar 28 2019
70.04
Maximum
Mar 28 2024
37.85
Average
34.97
Median
Price to Book Value Benchmarks
Amgen Inc | 24.59 |
Madrigal Pharmaceuticals Inc | 12.67 |
Vertex Pharmaceuticals Inc | 6.163 |
Viking Therapeutics Inc | 23.29 |
Moderna Inc | 3.010 |
Price to Book Value Related Metrics
PE Ratio | 138.53 |
PS Ratio | 20.83 |
Price | 787.75 |
Earnings Yield | 0.72% |
Market Cap | 748.97B |
Operating PE Ratio | 64.52 |
Normalized PE Ratio | 85.90 |